Exousia Bio (LMMY) Change in Cash (2022 - 2025)

Exousia Bio has disclosed Change in Cash across 4 years of filings, most recently posting -$1028.0 for Q1 2025.

• Change in Cash for Q1 2025 came in at -$1028.0, down 51300.0% year-over-year; the trailing twelve-month figure through Nov 2025 was -$1028.0 (changed N/A YoY), and the FY2025 annual result was -$1028.0, up 84.94% from the prior year.
• Change in Cash came in at -$1028.0 for Q1 2025 at Exousia Bio, down from $2.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3691.0 in Q2 2023 to a low of -$8321.0 in Q3 2022.
• The 4-year median for Change in Cash is -$290.0 (2023), against an average of -$1123.0.
• Across the five-year window, Change in Cash soared 33.33% in 2023 and plunged 51300.0% in 2025, its largest moves.
• Exousia Bio's Change in Cash stood at -$435.0 in 2022, then surged by 33.33% to -$290.0 in 2023, then surged by 100.69% to $2.0 in 2024, then tumbled by 51500.0% to -$1028.0 in 2025.
• The last three Change in Cash figures came in at -$1028.0 (Q1 2025), $2.0 (Q2 2024), and -$2.0 (Q1 2024), per Business Quant data.